正在加载视频...

视频加载失败

返回首页

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed...

JoeTippens_'s profile picture

Joe Tippens Protocol

12,581 subscribers

159,513 次观看 • 10 天前 •via X (Twitter)

新闻政治健康养生科学技术
LIVE

Anya Rossi• Live Now

Private livecam show

15 条评论

RF 的头像
RF9 天前

Where do I order from Spain? Or Italy?

Graham Long 的头像
Graham Long9 天前

I don't like Marcis as he has turned this into a lucrative business, you can get these protocols online for some years now

3GenCalifornian 的头像
3GenCalifornian9 天前

Melanoma?

SheWolf L 的头像
SheWolf L9 天前

Thank you

Dit2802 的头像
Dit28029 天前

I have heard that there is a negative impact to fertility when taking ivermectin. Is that correct?

winnie 的头像
winnie9 天前

@ryanmariebach78 I do hope your pet is doing well. These protocols have proven effective.

nobody 的头像
nobody10 天前

If not invermectin for Lymphoma than what, can't be cured at all with anything

Drama free 的头像
Drama free10 天前

How about thyroid cancer. It isn't mentioned?

JFR 的头像
JFR9 天前

This is all well and good but how do you get it? It requires a prescription. My primary care physician and urologist refuse to prescribe it. The Wellness Company (IMHO a scam) won’t talk to you until you pay for it FIRST $539/30 day supply, then you have to wait to talk to a physician that will determine if it’s OK and no drug interactions with your other meds, the wait is, who knows, they had NO APPOINTMENTS available, and if they won’t prescribe it, a lot of user reviews say getting the refund is often difficult, and if they do prescribe it, you can’t use medical insurance, and the only person you can get in the phone is from their Philippines call center who just read the same script over and over to all questions.

Debbie Hardy 的头像
Debbie Hardy9 天前

This 1.0mg/kg/day, does that include the ivermectin paste? Also does it include the fenbendazole paste?

Myxzlplk 的头像
Myxzlplk9 天前

I've been talking to my mom about doing this just as a prophylactic I'm considering it too I think people do that anyway

DogX 的头像
DogX9 天前

This account is from Cameroon.

Lynx 的头像
Lynx9 天前

@MakisMedicine should have been tagged.

Jimbo Elrod Jr. 的头像
Jimbo Elrod Jr.9 天前

What’s going on with assertions that Ivermectin feeds Morgellons?

Unfiltered #fella 🇺🇦🇺🇸🇪🇺 的头像
Unfiltered #fella 🇺🇦🇺🇸🇪🇺9 天前

Nobody has any recommendations for chronic lymphatic cancer in the watch and wait stage - anybody have any info !? All I’ve read it’s counter indicated !?

相关视频

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole
5:52

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole

PharmacyinUSA

91,716 次观看 • 4 个月前

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information. Follow for more .
1:00

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information. Follow for more .

mcgill_medicines

106,634 次观看 • 2 个月前

After a year of research, Dr. William Makis says this is the most important graph of his career. The ivermectin dosing schedule for cancer. For most cancers breast, colon, lung, pancreatic, renal, gastric, leukemias: Start at 1 mg per kg of body weight per day. For a 60 kg person: 60 mg daily. That's five 12 mg pills, or 6 mL of liquid. The evidence he cites is dose-dependent: 📉 Dr. Shankara Chetty prostate cancer patient's PSA dropped from 89 to 11 on 45 mg/day 📉 Dr. Tess Lawrie ovarian cancer marker CA-125 dropped from 288 to 22 on just 0.2 mg/kg 🧒 Castro study children with leukemia, no side effects after 6 months at 1 mg/kg For aggressive cancers (pancreatic, brain), the blood-brain barrier may need more: 🔹 Dr. Landrito's colleague — terminal gallbladder cancer, cancer disappeared after 14 months at 2 mg/kg/day 🔹 Highest documented dose: 2.5 mg/kg (Dr. Chetty) only transient visual side effects that resolved Why won't oncology offer this? Ivermectin is generic. Off-patent. Unprofitable. No funded trials. No incentive. No profit. Dr. Makis's conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." He suggests starting at 1 mg/kg/day. It can be taken for many months even over a year with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf. ⚠️ Not medical advice these are case reports and anecdotal evidence, not completed clinical trials. Never self-prescribe. Work with a doctor who listens.
5:46

After a year of research, Dr. William Makis says this is the most important graph of his career. The ivermectin dosing schedule for cancer. For most cancers breast, colon, lung, pancreatic, renal, gastric, leukemias: Start at 1 mg per kg of body weight per day. For a 60 kg person: 60 mg daily. That's five 12 mg pills, or 6 mL of liquid. The evidence he cites is dose-dependent: 📉 Dr. Shankara Chetty prostate cancer patient's PSA dropped from 89 to 11 on 45 mg/day 📉 Dr. Tess Lawrie ovarian cancer marker CA-125 dropped from 288 to 22 on just 0.2 mg/kg 🧒 Castro study children with leukemia, no side effects after 6 months at 1 mg/kg For aggressive cancers (pancreatic, brain), the blood-brain barrier may need more: 🔹 Dr. Landrito's colleague — terminal gallbladder cancer, cancer disappeared after 14 months at 2 mg/kg/day 🔹 Highest documented dose: 2.5 mg/kg (Dr. Chetty) only transient visual side effects that resolved Why won't oncology offer this? Ivermectin is generic. Off-patent. Unprofitable. No funded trials. No incentive. No profit. Dr. Makis's conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." He suggests starting at 1 mg/kg/day. It can be taken for many months even over a year with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf. ⚠️ Not medical advice these are case reports and anecdotal evidence, not completed clinical trials. Never self-prescribe. Work with a doctor who listens.

TheSkyMeds | Cancer & Parasites Explained

13,257 次观看 • 23 天前

🚨 “LOW TO VERY HIGH DOSES.” DR. WILLIAM MAKIS’ IVERMECTIN PROTOCOL FOR PARASITES, CANCER, FAMILY HISTORY & NEUROLOGICAL CONDITIONS Ivermectin is best known as an antiparasitic medicine. But Dr. William Makis discusses a much broader range of potential applications, including Parkinson’s disease, Alzheimer’s disease and cancer-related protocols. The accompanying Ivermectin protocol graphic organizes his reported dosing framework into four tiers. 📋 Ivermectin dosage framework shown in the chart Ivermectin Dosage Guide 🟢 LOW Anti-parasitic: 0.0267 g/kg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Cancer remission: 222 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Family history: 444 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days 🟡 MEDIUM Anti-parasitic / most cancers: 0.0535 g/kg • 6 days on, 1 day off • Until remission • Minimum 3 months Cancer: 444 mg • 6 days on, 1 day off • Until remission • Minimum 3 months 🔵 HIGH Aggressive cancers: 0.1070 g/kg • 6 days on, 1 day off • Until remission Leukemia, pancreatic, brain: 888–1,000 mg split doses • 6 days on, 1 day off • Until remission 🔴 VERY HIGH Terminal, metastatic cancers: 0.1337 g/kg • 6 days on, 1 day off • Short term Cancer: 1,500 mg split doses • 6 days on, 1 day off • Maximum 5 days ⚠️ Do not start any treatment without guidance from a doctor or qualified physician. 🧠 Then comes the neurological angle Makis says the neurological conditions where he has seen what he describes as the most success are: Parkinson’s disease + Alzheimer’s disease 1️⃣ Parkinson’s disease Makis describes cases involving what he calls high-dose Ivermectin, specifically mentioning: 60 mg → 72 mg He reports improvements in: • Movement • Mobility • Symptoms One patient he describes was barely mobile despite maximum standard treatment. After several weeks of high-dose Ivermectin, he says the patient started playing golf again, despite having been unable to play for years. He also says he has seen what he describes as reversal in a number of Parkinson’s patients. 2️⃣ Alzheimer’s disease This is where Makis says the stories became even more striking. He describes families reporting that elderly patients: • Recognized relatives again • Remembered people they had not recognized for years • Started reminiscing • Recalled old memories • Showed improved cognitive ability For these cases, he specifically discusses: 12 mg → 24 mg of Ivermectin He describes these amounts being used for several days in the cases he discusses. One particularly striking account involves a patient who was reportedly taken off hospice after improving. And the family reaction? “My grandma’s back.” Antiparasitic conditions. Cancer remission. Family history. Aggressive cancers. Metastatic cancers. Parkinson’s disease. Alzheimer’s disease. Different conditions. Different reported applications. Different reported dosing approaches. But one medicine: 💊 Ivermectin. 🔥 The breadth of the discussion is hard to ignore From an established antiparasitic medicine to reported applications involving cancer, Parkinson’s and Alzheimer’s, Ivermectin is now part of a much broader research conversation. Different conditions. Different reported experiences. One medicine generating very different questions across medicine. From antiparasitic protocols to reported cancer applications, Parkinson’s and Alzheimer’s cases, this video + protocol chart covers a lot. 🗨️ Which area deserves the most research attention: cancer, Parkinson’s, Alzheimer’s, parasites, or something else? 🔖 SAVE this post so you have Ivermectin dosing framework and the full video discussion handy. 🔄 REPOST to help others discover the broader research and clinical discussions surrounding Ivermectin. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Parkinsons #Alzheimers #Neurology #RepurposedMedicine #MakisMD #RxMeds
3:57

🚨 “LOW TO VERY HIGH DOSES.” DR. WILLIAM MAKIS’ IVERMECTIN PROTOCOL FOR PARASITES, CANCER, FAMILY HISTORY & NEUROLOGICAL CONDITIONS Ivermectin is best known as an antiparasitic medicine. But Dr. William Makis discusses a much broader range of potential applications, including Parkinson’s disease, Alzheimer’s disease and cancer-related protocols. The accompanying Ivermectin protocol graphic organizes his reported dosing framework into four tiers. 📋 Ivermectin dosage framework shown in the chart Ivermectin Dosage Guide 🟢 LOW Anti-parasitic: 0.0267 g/kg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Cancer remission: 222 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days Family history: 444 mg • 3 days on, 4 days off • Minimum 7 weeks • Supplements: OFF days 🟡 MEDIUM Anti-parasitic / most cancers: 0.0535 g/kg • 6 days on, 1 day off • Until remission • Minimum 3 months Cancer: 444 mg • 6 days on, 1 day off • Until remission • Minimum 3 months 🔵 HIGH Aggressive cancers: 0.1070 g/kg • 6 days on, 1 day off • Until remission Leukemia, pancreatic, brain: 888–1,000 mg split doses • 6 days on, 1 day off • Until remission 🔴 VERY HIGH Terminal, metastatic cancers: 0.1337 g/kg • 6 days on, 1 day off • Short term Cancer: 1,500 mg split doses • 6 days on, 1 day off • Maximum 5 days ⚠️ Do not start any treatment without guidance from a doctor or qualified physician. 🧠 Then comes the neurological angle Makis says the neurological conditions where he has seen what he describes as the most success are: Parkinson’s disease + Alzheimer’s disease 1️⃣ Parkinson’s disease Makis describes cases involving what he calls high-dose Ivermectin, specifically mentioning: 60 mg → 72 mg He reports improvements in: • Movement • Mobility • Symptoms One patient he describes was barely mobile despite maximum standard treatment. After several weeks of high-dose Ivermectin, he says the patient started playing golf again, despite having been unable to play for years. He also says he has seen what he describes as reversal in a number of Parkinson’s patients. 2️⃣ Alzheimer’s disease This is where Makis says the stories became even more striking. He describes families reporting that elderly patients: • Recognized relatives again • Remembered people they had not recognized for years • Started reminiscing • Recalled old memories • Showed improved cognitive ability For these cases, he specifically discusses: 12 mg → 24 mg of Ivermectin He describes these amounts being used for several days in the cases he discusses. One particularly striking account involves a patient who was reportedly taken off hospice after improving. And the family reaction? “My grandma’s back.” Antiparasitic conditions. Cancer remission. Family history. Aggressive cancers. Metastatic cancers. Parkinson’s disease. Alzheimer’s disease. Different conditions. Different reported applications. Different reported dosing approaches. But one medicine: 💊 Ivermectin. 🔥 The breadth of the discussion is hard to ignore From an established antiparasitic medicine to reported applications involving cancer, Parkinson’s and Alzheimer’s, Ivermectin is now part of a much broader research conversation. Different conditions. Different reported experiences. One medicine generating very different questions across medicine. From antiparasitic protocols to reported cancer applications, Parkinson’s and Alzheimer’s cases, this video + protocol chart covers a lot. 🗨️ Which area deserves the most research attention: cancer, Parkinson’s, Alzheimer’s, parasites, or something else? 🔖 SAVE this post so you have Ivermectin dosing framework and the full video discussion handy. 🔄 REPOST to help others discover the broader research and clinical discussions surrounding Ivermectin. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Parkinsons #Alzheimers #Neurology #RepurposedMedicine #MakisMD #RxMeds

RXMEDS.STORE

14,786 次观看 • 16 天前

🚨 “THE BEST RESULTS I’VE SEEN.” DR. WILLIAM MAKIS & DR. JOHN CAMPBELL DISCUSS IVERMECTIN + CHEMOTHERAPY FOR CANCER What happens when Dr. John Campbell asks Dr. William Makis to get specific about Ivermectin and cancer? The conversation quickly moves from theory to dose, timeline, cancer markers, imaging, and patient outcomes. 💊 WHERE DOES MAKIS START? Makis says the Ivermectin dose he discusses for intermediate to high-grade cancers starts around: 📌 1 mg/kg/day For lower-grade cancers, he says he starts lower, around: 📌 0.5 mg/kg/day He gives examples including CLL and multiple myeloma. 📅 WHY DOES HE TALK ABOUT 3 MONTHS? Makis says he suggests assessing Ivermectin use over approximately 3 months, followed by reassessment using: 🧪 Blood work 📊 Cancer markers 🩻 Follow-up imaging According to him, some changes in cancer markers can appear within 3–4 weeks. He specifically mentions: • PSA • CEA • CA-125 🩻 THEN COMES THE IMAGING Makis says tumor activity may begin changing on a PET scan in about a month. But physically seeing tumors or lymph nodes shrink can take longer. He says changes may begin appearing on: MRI → PET-CT → CT over approximately 2–3 months. 👀 THEN CAMPBELL ASKS ABOUT HIS MOST DRAMATIC RESULTS Makis' answer is the part that stands out: “The best results I’ve seen in my patients are patients who are doing a combination of chemotherapy and ivermectin.” 🔥 IVERMECTIN IS THE DETAIL THAT STANDS OUT. Makis says the best results he's seen have involved patients using Ivermectin alongside chemotherapy. That makes the question even more interesting: "Could Ivermectin have a larger role in cancer research than we currently understand?" ❓ THE BIGGER REPURPOSED-MEDICINE QUESTION This conversation puts Ivermectin + chemotherapy into a much bigger discussion about drug repurposing in cancer. What makes repurposed medicines so interesting? 💊 Existing medicines 🧬 Multiple biological pathways 🔬 New applications being investigated 📊 Different cancer types ⚡ Potential combination strategies And Ivermectin isn't the only repurposed medicine attracting attention. Fenbendazole. Mebendazole. Metformin. Doxycycline. Statins. Different medicines. Different mechanisms. But one common question: Could medicines we already have be hiding new possibilities in cancer research? THAT'S THE CONVERSATION WORTH WATCHING. 📌 SAVE this discussion for the next repurposed-medicine breakdown. 🔄️ REPOST if you think existing medicines deserve a second look in cancer research. 💊 Looking for Ivermectin or other repurposed medicines? Explore available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Chemotherapy #Cancer #DrWilliamMakis #DrJohnCampbell #RepurposedMedicine #MedicalResearch
3:33

🚨 “THE BEST RESULTS I’VE SEEN.” DR. WILLIAM MAKIS & DR. JOHN CAMPBELL DISCUSS IVERMECTIN + CHEMOTHERAPY FOR CANCER What happens when Dr. John Campbell asks Dr. William Makis to get specific about Ivermectin and cancer? The conversation quickly moves from theory to dose, timeline, cancer markers, imaging, and patient outcomes. 💊 WHERE DOES MAKIS START? Makis says the Ivermectin dose he discusses for intermediate to high-grade cancers starts around: 📌 1 mg/kg/day For lower-grade cancers, he says he starts lower, around: 📌 0.5 mg/kg/day He gives examples including CLL and multiple myeloma. 📅 WHY DOES HE TALK ABOUT 3 MONTHS? Makis says he suggests assessing Ivermectin use over approximately 3 months, followed by reassessment using: 🧪 Blood work 📊 Cancer markers 🩻 Follow-up imaging According to him, some changes in cancer markers can appear within 3–4 weeks. He specifically mentions: • PSA • CEA • CA-125 🩻 THEN COMES THE IMAGING Makis says tumor activity may begin changing on a PET scan in about a month. But physically seeing tumors or lymph nodes shrink can take longer. He says changes may begin appearing on: MRI → PET-CT → CT over approximately 2–3 months. 👀 THEN CAMPBELL ASKS ABOUT HIS MOST DRAMATIC RESULTS Makis' answer is the part that stands out: “The best results I’ve seen in my patients are patients who are doing a combination of chemotherapy and ivermectin.” 🔥 IVERMECTIN IS THE DETAIL THAT STANDS OUT. Makis says the best results he's seen have involved patients using Ivermectin alongside chemotherapy. That makes the question even more interesting: "Could Ivermectin have a larger role in cancer research than we currently understand?" ❓ THE BIGGER REPURPOSED-MEDICINE QUESTION This conversation puts Ivermectin + chemotherapy into a much bigger discussion about drug repurposing in cancer. What makes repurposed medicines so interesting? 💊 Existing medicines 🧬 Multiple biological pathways 🔬 New applications being investigated 📊 Different cancer types ⚡ Potential combination strategies And Ivermectin isn't the only repurposed medicine attracting attention. Fenbendazole. Mebendazole. Metformin. Doxycycline. Statins. Different medicines. Different mechanisms. But one common question: Could medicines we already have be hiding new possibilities in cancer research? THAT'S THE CONVERSATION WORTH WATCHING. 📌 SAVE this discussion for the next repurposed-medicine breakdown. 🔄️ REPOST if you think existing medicines deserve a second look in cancer research. 💊 Looking for Ivermectin or other repurposed medicines? Explore available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Chemotherapy #Cancer #DrWilliamMakis #DrJohnCampbell #RepurposedMedicine #MedicalResearch

RXMEDS.STORE

25,194 次观看 • 22 天前

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs
3:34

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

RXMEDS.STORE

37,820 次观看 • 3 个月前

💊 IVERMECTIN + FENBENDAZOLE FULL PROTOCOL: The Dosing Chart Being Shared Online Ivermectin by body weight 150 lb person • Low dose under 0.5 mg/kg → about 34 mg • Medium 1.0 mg/kg → about 68 mg • High 2.0 mg/kg → about 136 mg • Very high 2.5 mg/kg or more → about 170 mg 180 lb person • Low → about 41 mg • Medium → about 82 mg • High → about 164 mg • Very high → about 205 mg 200 lb person • Low → about 45 mg • Medium → about 91 mg • High → about 182 mg • Very high → about 227 mg Fenbendazole shown in the chart • Low: 222 mg, 3 days weekly • Medium: 222 mg, 3 days weekly • High: 222 mg, 6 days weekly • Very high: 222 mg, 6 days weekly The chart associates these doses with different cancer stages and also includes individual cancer testimonials. These are proposed, nonstandard regimens, not established cancer dosing guidelines. Ivermectin and Fenbendazole have not been proven to treat cancer at these doses, and fenbendazole is primarily a veterinary drug. Research into repurposed antiparasitic medicines, including Ivermectin, Fenbendazole, and Mebendazole, continues, but charts circulating online should not be treated as instructions for self-treatment. ⚕️ Follow Mcgill_Medicine for cancer research, repurposed-drug studies, and medical updates. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #DrugRepurposing #Oncology #MedicalResearch
4:02

💊 IVERMECTIN + FENBENDAZOLE FULL PROTOCOL: The Dosing Chart Being Shared Online Ivermectin by body weight 150 lb person • Low dose under 0.5 mg/kg → about 34 mg • Medium 1.0 mg/kg → about 68 mg • High 2.0 mg/kg → about 136 mg • Very high 2.5 mg/kg or more → about 170 mg 180 lb person • Low → about 41 mg • Medium → about 82 mg • High → about 164 mg • Very high → about 205 mg 200 lb person • Low → about 45 mg • Medium → about 91 mg • High → about 182 mg • Very high → about 227 mg Fenbendazole shown in the chart • Low: 222 mg, 3 days weekly • Medium: 222 mg, 3 days weekly • High: 222 mg, 6 days weekly • Very high: 222 mg, 6 days weekly The chart associates these doses with different cancer stages and also includes individual cancer testimonials. These are proposed, nonstandard regimens, not established cancer dosing guidelines. Ivermectin and Fenbendazole have not been proven to treat cancer at these doses, and fenbendazole is primarily a veterinary drug. Research into repurposed antiparasitic medicines, including Ivermectin, Fenbendazole, and Mebendazole, continues, but charts circulating online should not be treated as instructions for self-treatment. ⚕️ Follow Mcgill_Medicine for cancer research, repurposed-drug studies, and medical updates. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #DrugRepurposing #Oncology #MedicalResearch

PharmacyinUSA

47,779 次观看 • 5 天前

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch
4:26

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch

RXMEDS.STORE

26,054 次观看 • 12 天前

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 次观看 • 1 年前

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,224 次观看 • 2 个月前

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch
1:42

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch

RXMEDS.STORE

34,814 次观看 • 1 个月前

Joe Tippens protocol and Dosages. The updated Joe Tippens protocol is a combination of Fenbendazole, ivermectin, Mebendazole, vitamin b17 and TUDCA. The combination of this 5 ingredients have evidently shown to beat cancer in a period of just 120 days without any side effects. Today I will be explaining the dosage. (1) IVERMECTIN (Anti Parasitic medication) LOW DOSE 0.5 mg/kg Cancers in remission Strong family history Genetic predisposition Prophylaxis No long term side effects MEDIUM DOSE 1.0 mg/kg Starting dose for most cancers No long term side effects HIGH DOSE 2.0 mg/kg Dose for very aggressive cancers (leukemia, pancreas, brain cancers) No long term side effects VERY HIGH DOSE 2.5 mg/kg Extensive metastatic disease Extremely poor prognosis Brain cancers? (2) Mebendazole. LOW DOSE 100–200 mg twice daily (total 200–400 mg/day). HIGH DOSE 500 mg twice daily (1,000 mg/day) or 1,000–1,500 mg/day total. (3) VITAMIN B17 500 mg three or four times daily (1.5–2 g/day) or intravenous 3–9 g per day (4) FENBENDAZOLE LOW DOSE 222 mg once daily, 7 days a week. HIGH DOSE. 888–1,000 mg/day, or 222–1,000+ mg 6 days a week. (5) TUDCA 500mg twice daily. This is the complete Joe Tippens protocol, intended to be followed for 120 days. This regimen is not limited to people with cancer; it is also intended for individuals who suspect they may have parasites and for preventive or maintenance purposes. Therefore, it is presented as a protocol with no side effects. We have used this regimen since 2019 and have documented thousands of success stories from patients who chose this approach. At present, I am offering a special package containing all five ingredients mentioned above, including ivermectin paste for topical use. The package includes: .200 18-mg ivermectin pills, .200 444-mg fenbendazole pills, .200 500-mg mebendazole pills, .200 200-mg vitamin B17 pills, .10 tubes of ivermectin paste and .one bottle of TUDCA for $650. Each kit contains all the ingredients listed above for $650. These products were manufactured in the USA and have a shelf life of 4 years, allowing you to feel confident in the quality of the products you receive. If you are interested in obtaining a kit for yourself or for future use, please send me a private message or contact me on WhatsApp at +1 (640) 275-4099, and I will respond immediately. My prayers are with you all. Best regards,
0:53

Joe Tippens protocol and Dosages. The updated Joe Tippens protocol is a combination of Fenbendazole, ivermectin, Mebendazole, vitamin b17 and TUDCA. The combination of this 5 ingredients have evidently shown to beat cancer in a period of just 120 days without any side effects. Today I will be explaining the dosage. (1) IVERMECTIN (Anti Parasitic medication) LOW DOSE 0.5 mg/kg Cancers in remission Strong family history Genetic predisposition Prophylaxis No long term side effects MEDIUM DOSE 1.0 mg/kg Starting dose for most cancers No long term side effects HIGH DOSE 2.0 mg/kg Dose for very aggressive cancers (leukemia, pancreas, brain cancers) No long term side effects VERY HIGH DOSE 2.5 mg/kg Extensive metastatic disease Extremely poor prognosis Brain cancers? (2) Mebendazole. LOW DOSE 100–200 mg twice daily (total 200–400 mg/day). HIGH DOSE 500 mg twice daily (1,000 mg/day) or 1,000–1,500 mg/day total. (3) VITAMIN B17 500 mg three or four times daily (1.5–2 g/day) or intravenous 3–9 g per day (4) FENBENDAZOLE LOW DOSE 222 mg once daily, 7 days a week. HIGH DOSE. 888–1,000 mg/day, or 222–1,000+ mg 6 days a week. (5) TUDCA 500mg twice daily. This is the complete Joe Tippens protocol, intended to be followed for 120 days. This regimen is not limited to people with cancer; it is also intended for individuals who suspect they may have parasites and for preventive or maintenance purposes. Therefore, it is presented as a protocol with no side effects. We have used this regimen since 2019 and have documented thousands of success stories from patients who chose this approach. At present, I am offering a special package containing all five ingredients mentioned above, including ivermectin paste for topical use. The package includes: .200 18-mg ivermectin pills, .200 444-mg fenbendazole pills, .200 500-mg mebendazole pills, .200 200-mg vitamin B17 pills, .10 tubes of ivermectin paste and .one bottle of TUDCA for $650. Each kit contains all the ingredients listed above for $650. These products were manufactured in the USA and have a shelf life of 4 years, allowing you to feel confident in the quality of the products you receive. If you are interested in obtaining a kit for yourself or for future use, please send me a private message or contact me on WhatsApp at +1 (640) 275-4099, and I will respond immediately. My prayers are with you all. Best regards,

Joe Tippens

53,425 次观看 • 29 天前

🚨 THIS DOCTOR SAYS IVERMECTIN DOSING CAN CHANGE COMPLETELY DEPENDING ON WHY IT’S BEING USED Most people hear “Ivermectin” and think of one standard dose. That isn't how the speaker in this clip approaches it. They explain that their calculations start with body weight, converting pounds to kilograms, and then applying a milligram-per-kilogram amount based on the situation. For example, they describe: • 0.2 mg/kg for what they call prevention • 0.3 mg/kg for their parasite-cleanse approach • 0.4 to 0.6 mg/kg for patients they describe as having COVID, flu or RSV • For cancer, they say the amount depends on the type, stage and progression, with some aggressive approaches reaching 1 mg/kg or higher They also describe rounding calculated doses to an available strength. Their example: if the calculation comes out to 32 mg, they might prescribe 35 mg. And that's where this conversation gets controversial. The speaker isn't describing one fixed Ivermectin dose. They're describing a range that changes according to the condition and their treatment approach, with cancer being the most aggressive end of the range. But these numbers should be understood as the speaker's claimed clinical approach, not a dosing guide. Ivermectin dosing is indication-specific, and the higher doses described here can carry significant safety concerns. Ivermectin is not an established treatment for COVID-19 or cancer. #Ivermectin #IvermectinResearch #DrugRepurposing #CancerResearch #Pharmacology #MedicalResearch
1:42

🚨 THIS DOCTOR SAYS IVERMECTIN DOSING CAN CHANGE COMPLETELY DEPENDING ON WHY IT’S BEING USED Most people hear “Ivermectin” and think of one standard dose. That isn't how the speaker in this clip approaches it. They explain that their calculations start with body weight, converting pounds to kilograms, and then applying a milligram-per-kilogram amount based on the situation. For example, they describe: • 0.2 mg/kg for what they call prevention • 0.3 mg/kg for their parasite-cleanse approach • 0.4 to 0.6 mg/kg for patients they describe as having COVID, flu or RSV • For cancer, they say the amount depends on the type, stage and progression, with some aggressive approaches reaching 1 mg/kg or higher They also describe rounding calculated doses to an available strength. Their example: if the calculation comes out to 32 mg, they might prescribe 35 mg. And that's where this conversation gets controversial. The speaker isn't describing one fixed Ivermectin dose. They're describing a range that changes according to the condition and their treatment approach, with cancer being the most aggressive end of the range. But these numbers should be understood as the speaker's claimed clinical approach, not a dosing guide. Ivermectin dosing is indication-specific, and the higher doses described here can carry significant safety concerns. Ivermectin is not an established treatment for COVID-19 or cancer. #Ivermectin #IvermectinResearch #DrugRepurposing #CancerResearch #Pharmacology #MedicalResearch

PharmacyinUSA

18,266 次观看 • 27 天前

According to Dr. William Makis, high-dose ivermectin shows tremendous promise for treating a majority of cancers. The required dose is significant – about 1mg/kg, or 60mg daily for a 60kg person – far higher than what was discussed for COVID-19. So why isn't this being rushed into clinical trials? The answer, Dr. Makis reveals, is a story of profit over patients. Ivermectin is off-patent. No pharmaceutical company can monopolize profits from it, so they have no incentive to fund research. In a stunning revelation, Dr. Makis connects the dots: Merck, the original patent holder, actively badmouthed ivermectin during COVID. The reason? They are in a 50-50 partnership with Moderna on a new mRNA cancer vaccine. Pushing a cheap, generic cure would directly threaten their future billion-dollar profits. But the story doesn't end there. Dr. Makis also highlights the power of repurposed anti-parasitics like fenbendazole and its FDA-approved human version, mebendazole. These drugs work by upregulating p53, a critical tumor suppressor protein. This is crucial because emerging research suggests the COVID-19 vaccine spike protein may downregulate p53, a potential mechanism for the turbo-cancers being observed. Treatments like mebendazole offer a direct counter to this effect, something conventional chemo and radiation do not. The solution? Dr. Makis advocates for public policy that directs government cancer funding toward off-patent, repurposed drugs. This takes the politics and profiteering out of the equation, allowing science to focus on what truly matters: saving lives.
4:01

According to Dr. William Makis, high-dose ivermectin shows tremendous promise for treating a majority of cancers. The required dose is significant – about 1mg/kg, or 60mg daily for a 60kg person – far higher than what was discussed for COVID-19. So why isn't this being rushed into clinical trials? The answer, Dr. Makis reveals, is a story of profit over patients. Ivermectin is off-patent. No pharmaceutical company can monopolize profits from it, so they have no incentive to fund research. In a stunning revelation, Dr. Makis connects the dots: Merck, the original patent holder, actively badmouthed ivermectin during COVID. The reason? They are in a 50-50 partnership with Moderna on a new mRNA cancer vaccine. Pushing a cheap, generic cure would directly threaten their future billion-dollar profits. But the story doesn't end there. Dr. Makis also highlights the power of repurposed anti-parasitics like fenbendazole and its FDA-approved human version, mebendazole. These drugs work by upregulating p53, a critical tumor suppressor protein. This is crucial because emerging research suggests the COVID-19 vaccine spike protein may downregulate p53, a potential mechanism for the turbo-cancers being observed. Treatments like mebendazole offer a direct counter to this effect, something conventional chemo and radiation do not. The solution? Dr. Makis advocates for public policy that directs government cancer funding toward off-patent, repurposed drugs. This takes the politics and profiteering out of the equation, allowing science to focus on what truly matters: saving lives.

Camus

89,212 次观看 • 10 个月前

🚨 “MY GRANDMA’S BACK.” DR. WILLIAM MAKIS ON THE IVERMECTIN PROTOCOL HE REPORTS USING FOR NEUROLOGICAL CONDITIONS Most people know Ivermectin for its antiparasitic use. But Dr. William Makis says another area deserves far more attention: Neurological conditions. He specifically discusses Parkinson’s disease and Alzheimer’s disease, along with several other neurological conditions shown in the accompanying dosing graphic. 🧠 Parkinson’s disease Makis describes using high-dose Ivermectin and reports amounts around: 💊 60–72 mg/day Makis says patients experienced improvements in symptoms and movement. One patient, he says, was barely mobile despite maximum standard treatment. After several weeks, he says she was playing golf again. “And I've seen reversal in a number of Parkinson's disease patients.” 🧠 Alzheimer’s & dementia This is where Makis says the stories became even more striking. He describes reported amounts of: 💊 12 mg 💊 12–24 mg for several days According to his account, some families reported that elderly patients began: ✅ Recognizing relatives they hadn't recognized for years ✅ Remembering old experiences ✅ Reminiscing ✅ Showing improved cognitive ability Then comes the quote that stands out: “My grandma’s back.” Makis says families told him their loved ones had their memories and sense of humor back. He also describes one patient who, according to his account, was taken off hospice because of improvement. 📊 The reported neurological protocol The reported human neurological Ivermectin dosing across conditions including: • Parkinson’s disease • Parkinsonism • Alzheimer’s/dementia • Drug-resistant epilepsy • Neurocysticercosis • Huntington’s chorea • Tremor • Dystonia The video includes different reported dosing ranges and identifies different evidence types, from case reports and physician-reported cases to observational studies and clinical research. 🔥 But the most powerful part isn't the numbers It's what Makis says families describe afterward. “The moments that the family gets back are so precious.” ⁉️ Why this conversation matters From Parkinson’s and Alzheimer’s to epilepsy, tremor and dystonia, Makis says he has seen a much broader neurological side of Ivermectin than most people realize. For families facing neurological disease, even the possibility of better movement, clearer memories and more meaningful time with loved ones can mean everything. Ivermectin is now part of a much bigger neurological research conversation, and there is still much to explore. 📌 SAVE this breakdown and come back to it. 🔄 REPOST to help keep the neurological Ivermectin conversation moving. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #NeurologicalConditions #Parkinsons #Alzheimers #Dementia #Neurology #RepurposedMedicine #MedicalResearch
4:02

🚨 “MY GRANDMA’S BACK.” DR. WILLIAM MAKIS ON THE IVERMECTIN PROTOCOL HE REPORTS USING FOR NEUROLOGICAL CONDITIONS Most people know Ivermectin for its antiparasitic use. But Dr. William Makis says another area deserves far more attention: Neurological conditions. He specifically discusses Parkinson’s disease and Alzheimer’s disease, along with several other neurological conditions shown in the accompanying dosing graphic. 🧠 Parkinson’s disease Makis describes using high-dose Ivermectin and reports amounts around: 💊 60–72 mg/day Makis says patients experienced improvements in symptoms and movement. One patient, he says, was barely mobile despite maximum standard treatment. After several weeks, he says she was playing golf again. “And I've seen reversal in a number of Parkinson's disease patients.” 🧠 Alzheimer’s & dementia This is where Makis says the stories became even more striking. He describes reported amounts of: 💊 12 mg 💊 12–24 mg for several days According to his account, some families reported that elderly patients began: ✅ Recognizing relatives they hadn't recognized for years ✅ Remembering old experiences ✅ Reminiscing ✅ Showing improved cognitive ability Then comes the quote that stands out: “My grandma’s back.” Makis says families told him their loved ones had their memories and sense of humor back. He also describes one patient who, according to his account, was taken off hospice because of improvement. 📊 The reported neurological protocol The reported human neurological Ivermectin dosing across conditions including: • Parkinson’s disease • Parkinsonism • Alzheimer’s/dementia • Drug-resistant epilepsy • Neurocysticercosis • Huntington’s chorea • Tremor • Dystonia The video includes different reported dosing ranges and identifies different evidence types, from case reports and physician-reported cases to observational studies and clinical research. 🔥 But the most powerful part isn't the numbers It's what Makis says families describe afterward. “The moments that the family gets back are so precious.” ⁉️ Why this conversation matters From Parkinson’s and Alzheimer’s to epilepsy, tremor and dystonia, Makis says he has seen a much broader neurological side of Ivermectin than most people realize. For families facing neurological disease, even the possibility of better movement, clearer memories and more meaningful time with loved ones can mean everything. Ivermectin is now part of a much bigger neurological research conversation, and there is still much to explore. 📌 SAVE this breakdown and come back to it. 🔄 REPOST to help keep the neurological Ivermectin conversation moving. 💊 Looking for Ivermectin? Discover available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #NeurologicalConditions #Parkinsons #Alzheimers #Dementia #Neurology #RepurposedMedicine #MedicalResearch

RXMEDS.STORE

57,090 次观看 • 14 天前

🚨Ivermectin dosage for Cancer by William Makis In this clip, William Makis walks through an academic discussion on how ivermectin is evaluated in cancer settings and what he watches for first. According to Dr. William Makis, that's often not what happens. He explains that when patients respond to ivermectin, the earliest signs can appear in blood markers long before CT scans or MRIs show visible changes. Those imaging changes may take weeks or even months to catch up. That delay can lead people to assume nothing is happening and stop too early. If you're researching ivermectin, fenbendazole, or mebendazole protocols, understanding how response is measured may be just as important as the protocol itself. For those looking for a trusted source, many people choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. We provide seamless worldwide delivery of them 🚚🌎 #Ivermectin #WilliamMakis #CancerResearch #CancerAwareness
3:33

🚨Ivermectin dosage for Cancer by William Makis In this clip, William Makis walks through an academic discussion on how ivermectin is evaluated in cancer settings and what he watches for first. According to Dr. William Makis, that's often not what happens. He explains that when patients respond to ivermectin, the earliest signs can appear in blood markers long before CT scans or MRIs show visible changes. Those imaging changes may take weeks or even months to catch up. That delay can lead people to assume nothing is happening and stop too early. If you're researching ivermectin, fenbendazole, or mebendazole protocols, understanding how response is measured may be just as important as the protocol itself. For those looking for a trusted source, many people choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. We provide seamless worldwide delivery of them 🚚🌎 #Ivermectin #WilliamMakis #CancerResearch #CancerAwareness

GENIX MEDS

11,857 次观看 • 4 个月前

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."
1:59

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

228,848 次观看 • 10 个月前

Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."
4:27

Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."

Sense Receptor

96,616 次观看 • 10 个月前

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin
1:02

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin

PharmacyinUSA

45,592 次观看 • 3 个月前

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

46,883 次观看 • 2 个月前